| 000 | 01580 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516192230.0 | ||
| 264 | 0 | _c20150406 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1521-4184 | ||
| 024 | 7 |
_a10.1002/ardp.201300325 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLing, Yong | |
| 245 | 0 | 0 |
_aSynthesis and biological evaluation of novel farnesylthiosalicylic acid derivatives for cancer treatment. _h[electronic resource] |
| 260 |
_bArchiv der Pharmazie _cMay 2014 |
||
| 300 |
_a327-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFarnesol _xanalogs & derivatives |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aSalicylates _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aras Proteins _xmetabolism |
| 700 | 1 | _aWang, Xuemin | |
| 700 | 1 | _aZhu, Hongyan | |
| 700 | 1 | _aWang, Zhiqiang | |
| 700 | 1 | _aXu, Chenjun | |
| 700 | 1 | _aWang, Xinyang | |
| 700 | 1 | _aChen, Li | |
| 700 | 1 | _aZhang, Wei | |
| 773 | 0 |
_tArchiv der Pharmazie _gvol. 347 _gno. 5 _gp. 327-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ardp.201300325 _zAvailable from publisher's website |
| 999 |
_c23459621 _d23459621 |
||